Biopharmaceutical Consultants LLC is categorized under Business Consultants in New Hope, PA and active since 2010.
Biopharmaceutical Consultants LLC was established in 2010, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 541618 by the NAICS.
If you are seeking more information, feel free to contact Joseph Tempio at the company’s single location by writing to 1679 Lookaway Court, New Hope, Pennsylvania PA 18938 or by phoning (267) 265-5466. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Biopharmaceutical Consultants LLC |
| Contact Person: | Joseph Tempio |
| Address: | 1679 Lookaway Court, New Hope, Pennsylvania 18938 |
| Phone Number: | (267) 265-5466 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Consultants |
| SIC Code: | 8748 |
| NAICS Code: | 541618 |
| Share This Business: |
Biopharmaceutical Consultants LLC was started in 2010 to provide professional Business Consultants under the SIC code 8748 and NAICS code 541618. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Joseph Tempio for inquiries that concern Biopharmaceutical Consultants LLC by calling the company number (267) 265-5466, as your correspondence is most welcome. Additionally, the physical location of the single location of Biopharmaceutical Consultants LLC can be found at the coordinates 40.297914,-75.049633 as well as the street address 1679 Lookaway Court in New Hope, Pennsylvania 18938.
For its online presence, you may visit Biopharmaceutical Consultants LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.